397244-87-0 Usage
Uses
Used in Pharmaceutical Industry:
4-Piperidinone,1-[(2,6-dimethoxyphenyl)methyl]is used as a key intermediate in the synthesis of various pharmaceutical compounds for its structural and functional versatility, contributing to the development of new drugs with improved therapeutic profiles.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Piperidinone,1-[(2,6-dimethoxyphenyl)methyl]serves as a crucial component in the creation of agrochemical products, potentially enhancing crop protection and yield through its integration into pesticides or other related chemicals.
Used in Organic Synthesis:
4-Piperidinone,1-[(2,6-dimethoxyphenyl)methyl]is utilized as a building block in organic synthesis, providing a foundation for the construction of complex organic molecules with diverse applications in various chemical and material sciences.
Used in Research and Development:
4-Piperidinone,1-[(2,6-dimethoxyphenyl)methyl]is also used in research and development settings to explore its pharmacological properties, particularly as a 5-HT2C serotonin receptor antagonist, which can lead to advancements in understanding and treating related neurological and psychiatric disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 397244-87-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,7,2,4 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 397244-87:
(8*3)+(7*9)+(6*7)+(5*2)+(4*4)+(3*4)+(2*8)+(1*7)=190
190 % 10 = 0
So 397244-87-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H19NO3/c1-17-13-4-3-5-14(18-2)12(13)10-15-8-6-11(16)7-9-15/h3-5H,6-10H2,1-2H3
397244-87-0Relevant academic research and scientific papers
SUBSTITUTED 4-AMINO-1-BENZYLPIPERIDINE COMPOUNDS
-
Page 78-79, (2008/06/13)
This invention provides 4-amino-1-benzylpiperidine and related compounds and pharmaceutically acceptable salts thereof which are useful as muscarinic receptor antagonists. This invention also provides pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors, such as overactive bladder, irritable bowel syndrome, asthma and chronic obstructive pulmonary disease, using such compounds.
